About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Glivec Enhances Survival Rates In Leukemia

by Medindia Content Team on June 6, 2006 at 8:18 PM
Font : A-A+

Glivec Enhances Survival Rates In Leukemia

Glivec, a drug used to treat chronic myeloid leukemia has shown to improve the survival rates in 90 percent of patients with the cancer. The National Institute for health and Clinical Excellence (NICE), which regulates drug approvals in the UK had only wanted to approve Glivec for advanced cases, but the drug has not proved itself in clinical trials.

CML is a common form of blood cancer, which arises due to a defect in the production of white blood cells. Glivec targets only the affected molecules and leaves the healthy ones unaffected. But it is an expensive drug and costs at least Ģ14,000 per patient per year.

Advertisement

Results from the IRIS study showed that 93 percent of patients taking the drug in early stages did not progress to advanced stage. Also 83 percent had good survival rate of five years. Before the introduction of Glivec, CML had poor prognosis with survival rates of only four to six years.

Sandy Craine, from CML Support, who took part in the trial said, "I never would have believed I would be standing here today. Glivec helped save my life and I am grateful that I can pass on this message of hope to others diagnosed with this once devastating disease."

Professor Charles Craddock, director of Stem Cell Transplant Unit, Queen Elizabeth Hospital, Birmingham, added, "The significant success of Glivec in treating CML is an exciting model for the development of new treatments for other cancers."
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Leukemia Chronic Myeloid Leukemia Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Multiple Myeloma 

Most Popular on Medindia

The Essence of Yoga Indian Medical Journals Sinopril (2mg) (Lacidipine) Drug Side Effects Calculator Color Blindness Calculator Pregnancy Confirmation Calculator Find a Hospital Drug - Food Interactions Loram (2 mg) (Lorazepam) Post-Nasal Drip
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Glivec Enhances Survival Rates In Leukemia Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests